|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-3-24
|
|
pubmed:abstractText |
In patients with locoregional carcinoma of the esophagus or esophagogastric junction who underwent preoperative chemoradiation, it is unclear whether survival was better predicted by pretherapy clinical stage or by posttherapy pathologic stage.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2005 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1347-55
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15719440-Carcinoma,
pubmed-meshheading:15719440-Chemotherapy, Adjuvant,
pubmed-meshheading:15719440-Combined Modality Therapy,
pubmed-meshheading:15719440-Disease-Free Survival,
pubmed-meshheading:15719440-Esophageal Neoplasms,
pubmed-meshheading:15719440-Esophagectomy,
pubmed-meshheading:15719440-Female,
pubmed-meshheading:15719440-Humans,
pubmed-meshheading:15719440-Lymphatic Metastasis,
pubmed-meshheading:15719440-Male,
pubmed-meshheading:15719440-Middle Aged,
pubmed-meshheading:15719440-Neoadjuvant Therapy,
pubmed-meshheading:15719440-Prognosis,
pubmed-meshheading:15719440-Radiotherapy, Adjuvant,
pubmed-meshheading:15719440-Survival Rate
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
|
|
pubmed:affiliation |
Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
